PlainVisa
2026 data Public-data reference Official source

Asklepios BioPharmaceutical, Inc.

A DOL Labor Condition Application record spanning FY2023–2024. Review the filing volume, DOL certification record, and offered-wage context below.

DOL LCA filings
6
DOL-certified
83.3%
Median offered wage
$160,428

Research Triangle Park, NC NAICS: 325414

Asklepios BioPharmaceutical, Inc., by the LCA numbers

U.S. Department of Labor's OFLC discloses 6 Labor Condition Application filings naming Asklepios BioPharmaceutical, Inc. from FY2023 through FY2024, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs

USCIS adjudication record for Asklepios BioPharmaceutical, Inc.

Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 16 H-1B petitions naming Asklepios BioPharmaceutical, Inc. through FY2024, and approved the large majority of them: 93.8% approved (15 approvals, 1 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.

The verdict

Asklepios BioPharmaceutical, Inc. is listed in 6 DOL LCA filings, more filings than 80% of employer filers in this extract. DOL certified 83.3% of those LCAs; the median listed offered wage is $160,428. This is not a USCIS approval, hiring, or sponsorship ranking.

6
DOL LCA filings, FY2023–FY2024
83.3%
DOL-certified
$160,428
median offered wage
Top 20%
of employer filers by volume

According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2024). Based in Research Triangle Park, NC.

Saved on this device only, no account, no email. Open saved list Follow this profile's data updates Updates when the published DOL data vintage changes; this is a feed, not an alert service.

Asklepios BioPharmaceutical, Inc. vs all U.S. employer filers by LCA volume

Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)

6 28534th of 122824 higher than 94,290 of 122,824 employer filers

Employer filers, banded by disclosed H-1B LCA filing count

Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source U.S. Department of Labor OFLC · FY2023–FY2024

LCA filing shape · Asklepios BioPharmaceutical, Inc.

Derived from this employer's disclosed LCAs on file (FY2023–FY2024), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.

Offered-wage span on file: $109,000$250,000 .

Title concentration

  • Senior Scientist, Group Lead 2 · 33.3% · $109,000
  • Director - Safety Operations, Quality, and Compliance 2 · 33.3% · $250,000
  • Scientist IV 1 · 16.7% · $127,067
  • Scientist II, Molecular Biology 1 · 16.7% · $117,500

Worksite counties

  • DURHAM, NC 4 · 66.7%
  • ACTON, MA 2 · 33.3%

Above-prevailing wage posture

On 6 LCAs with comparable offered vs prevailing wages, Asklepios BioPharmaceutical, Inc. averages about 10.8% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (66.7% of LCA filings).

Certification Rate

83.3%

Lower DOL cert

Avg. Salary

$160,428

Well above portal avg

Total Workers

6

Small worker count

Wondering how long it takes USCIS to process an H-1B petition for this employer? See current I-129 processing times →

Salary Analysis

Compensation range for H-1B positions at Asklepios BioPharmaceutical, Inc.

Minimum
$109,000
Maximum
$250,000
Average Salary
$160,428

Wage vs. DOL Minimum

+10.8%

At/above DOL floor

national avg +17.8%

Typical DOL Wage Level

Fully Competent (Level IV)

66.7% of LCA filings

Full-Time Positions

100%

Primary Worksite County

DURHAM, NC

66.7% of LCA filings

Top Occupations

Most frequently listed job titles at Asklepios BioPharmaceutical, Inc.

Job Title LCA filings Avg. Salary
Senior Scientist, Group Lead 2 $109,000
Director - Safety Operations, Quality, and Compliance 2 $250,000
Scientist IV 1 $127,067
Scientist II, Molecular Biology 1 $117,500

Nationwide peers near Asklepios BioPharmaceutical, Inc.'s 6-LCA band

Cross-state DOL neighbors for Asklepios BioPharmaceutical, Inc. - LCA filing-count and offered-wage axes, outside NC.

Similar avg offered wage

Cross-state employer filers with a comparable average listed offered wage ($160,428 here).

Frequently Asked Questions

What is Asklepios BioPharmaceutical, Inc.'s H-1B LCA filing count?

Asklepios BioPharmaceutical, Inc. is listed in 6 DOL Labor Condition Application filings covering 6 listed worker positions from FY2023 to FY2024. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.

How does Asklepios BioPharmaceutical, Inc.'s LCA filing volume compare to other employer filers?

Among 122,824 employer filers in the DOL disclosure extract, Asklepios BioPharmaceutical, Inc. ranks #25162 by total LCA filing count (6 filings). 94,290 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.

How often are Asklepios BioPharmaceutical, Inc.'s LCAs certified by the Labor Department?

Asklepios BioPharmaceutical, Inc. has a 83.3% DOL certification rate, with 5 out of 6 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.

What offered wage is listed in LCAs for Asklepios BioPharmaceutical, Inc.?

The average offered wage listed in Asklepios BioPharmaceutical, Inc.'s LCAs is $160,428. Listed wages range from $109,000 to $250,000 and are not verified actual compensation.

What are the most common H-1B job titles at Asklepios BioPharmaceutical, Inc.?

The top job titles in Asklepios BioPharmaceutical, Inc.'s LCA filing records include Senior Scientist, Group Lead, Director - Safety Operations, Quality, and Compliance, Scientist IV. The most common listed title is Senior Scientist, Group Lead with 2 LCA filings at an average listed offered wage of $109,000. This does not establish actual job openings, hiring, or approved petitions.

What city and state is Asklepios BioPharmaceutical, Inc. based in?

Asklepios BioPharmaceutical, Inc. is headquartered in Research Triangle Park, NC. Their H-1B workers are distributed across 2 states, with the most positions in NC, MA.

Does Asklepios BioPharmaceutical, Inc. qualify as an H-1B dependent employer?

No, Asklepios BioPharmaceutical, Inc. is not classified as H-1B dependent.

What is the year-over-year trend in Asklepios BioPharmaceutical, Inc.'s LCA filings?

Asklepios BioPharmaceutical, Inc. is listed in 5 LCA filings in FY2023 and 1 in FY2024. The average listed offered wage changed from $167,100 to $127,067. This historical filing series does not predict sponsorship, hiring, or visa outcomes.

Data sourced from U.S. Department of Labor LCA disclosure filings. See our methodology for details.

Disclaimer: Informational only, not professional advice.

Read with Asklepios BioPharmaceutical, Inc.

ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps TRACE-BOOK · CERT-SOFT · WAGE-ELITE.

What to do with this profile

Use the DOL LCA record for Asklepios BioPharmaceutical, Inc. to compare filing volume and offered wages, not USCIS outcomes.

DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.

Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.